학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 13건 | 목록 1~20
Academic Journal
Mol Oncol
Molecular Oncology, Vol 9, Iss 7, Pp 1274-1286 (2015)
Molecular Oncology, 9, 7, pp. 1274-86
Schouten, P C, Grigoriadis, A, Kuilman, T, Mirza, H, Watkins, J A, Cooke, S A, van Dyk, E, Severson, T M, Rueda, O M, Hoogstraat, M, Verhagen, C V M, Natrajan, R, Chin, S-F, Lips, E H, Kruizinga, J, Velds, A, Nieuwland, M, Kerkhoven, R M, Krijgsman, O, Vens, C, Peeper, D, Nederlof, P M, Caldas, C, Tutt, A N, Wessels, L F & Linn, S C 2015, ' Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms ', Molecular Oncology, vol. 9, no. 7, pp. 1274-86 . https://doi.org/10.1016/j.molonc.2015.03.002
Molecular Oncology
Academic Journal
Hoffmann RM; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, King's College London, London, United Kingdom.; Coumbe BGT; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; School of Clinical Medicine, University College London Medical School, London, United Kingdom.; Josephs DH; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom.; Mele S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; Ilieva KM; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; Cheung A; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; Tutt AN; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; Spicer JF; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom.; Thurston DE; Institute of Pharmaceutical Science, King's College London, Britannia House, London, United Kingdom.; Femtogenix Ltd, BioPark, Welwyn Garden City, Hertfordshire, United Kingdom.; Crescioli S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, King's College London, London, United Kingdom.; Karagiannis SN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Tower Wing, Guy's Hospital, London, United Kingdom.; NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, King's College London, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Academic Journal
Ilieva KM; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Unit, School of Cancer Sciences, Guy's Cancer Centre, King's College London, London, United Kingdom.; Fazekas-Singer J; Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, University of Vienna, Vienna, Austria.; Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Achkova DY; School of Cancer Sciences, King's College London, Bermondsey Wing, Guy's Hospital, London, United Kingdom.; Dodev TS; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Randall Division of Cell and Molecular Biophysics, King's College London, New Hunt's House, London, United Kingdom.; Mele S; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Crescioli S; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Bax HJ; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Cheung A; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Unit, School of Cancer Sciences, Guy's Cancer Centre, King's College London, London, United Kingdom.; Karagiannis P; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Department of Oncology, Haematology and Stem Cell Transplantation, University Hospital of Hamburg Eppendorf, Hamburg, Germany.; Correa I; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Figini M; Molecular Therapies Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.; Marlow R; Breast Cancer Now Unit, School of Cancer Sciences, Guy's Cancer Centre, King's College London, London, United Kingdom.; Josephs DH; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; School of Cancer Sciences, King's College London, Bermondsey Wing, Guy's Hospital, London, United Kingdom.; Beavil AJ; Randall Division of Cell and Molecular Biophysics, King's College London, New Hunt's House, London, United Kingdom.; Maher J; School of Cancer Sciences, King's College London, Bermondsey Wing, Guy's Hospital, London, United Kingdom.; Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, London, United Kingdom.; Department of Immunology, Eastbourne Hospital, Eastbourne, United Kingdom.; Spicer JF; School of Cancer Sciences, King's College London, Bermondsey Wing, Guy's Hospital, London, United Kingdom.; Jensen-Jarolim E; Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, University of Vienna, Vienna, Austria.; Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Tutt AN; Breast Cancer Now Unit, School of Cancer Sciences, Guy's Cancer Centre, King's College London, London, United Kingdom.; Karagiannis SN; St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Unit, School of Cancer Sciences, Guy's Cancer Centre, King's College London, London, United Kingdom.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Academic Journal
Turner NC; Institute of Cancer Research and Royal Marsden, London, United Kingdom.; Balmaña J; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Poncet C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Goulioti T; Breast International Group, Brussels, Belgium.; Tryfonidis K; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Honkoop AH; Borstkanker Onderzoeksgroep Nederland (BOOG), Amsterdam, the Netherlands.; Zoppoli G; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy, and Ospedale Policlinico IRCCS San Martino and Università degli Studi di Genova, Genova, Italy.; Razis E; Hygeia Hospital, Marousi, Athens, Greece.; Johannsson OT; Department of Clinical Oncology, Landspitali The National University Hospital of Iceland, Reykjavik, Iceland.; Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Tutt AN; Guy's and St Thomas's NHS Foundation Trust and The Breast Cancer Now Toby Robins Breast Cancer Research Center, The Institute of Cancer Research, London, United Kingdom.; Audeh W; Cedars-Sinai Cancer Center, Los Angeles, California.; Agendia, Inc., Irvine, California.; Ignatiadis M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Mailliez A; Center Oscar Lambret, Lille, France.; Trédan O; Center Léon Bérard, Lyon, France.; Musolino A; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy, and Medical Oncology and Breast Unit, University Hospital of Parma, Department of Medicine and Surgery, University of Parma, Parma, Italy.; Vuylsteke P; UCLouvain, CHU Namur, Belgium and University of Botswana, Gaborone, Botswana.; Juan-Fita MJ; Instituto Valenciano de Oncología, Valencia, Spain, and GEICAM Spanish Breast Cancer Group.; Macpherson IRJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Kaufman B; Sheba Medical Center, Ramat Gan, Israel.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain.; Goldstein LJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Ellard SL; BC Cancer, Kelowna, British Columbia, Canada.; Láng I; Istenhegyi Gèndiagnosztika Private Health Center Oncology Unit, Budapest, Hungary.; Jen KY; GlaxoSmithKline/Tesaro, Waltham, Massachusetts.; Adam V; Breast International Group, Brussels, Belgium.; Litière S; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Erban J; Tufts University School of Medicine, Boston, Massachusetts.; Cameron DA
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Peck B; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Bland P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Mavrommati I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Cottom H; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Wai PT; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Maguire SL; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.; Barker HE; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Stem Cells and Cancer, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Morrison E; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Kriplani D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Yu L; Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom.; Gibson A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Falgari G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Brennan K; Faculty of Life Sciences, University of Manchester, Manchester, England, United Kingdom.; Farnie G; SGC Oxford, University of Oxford, Oxford, England, United Kingdom.; Buus R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Marlow R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom.; Novo D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Knight E; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Kolarevic D; The Royal Marsden NHS Foundation Trust, London, England, United Kingdom.; Susnjar S; Department of Medical Oncology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.; Milijic NM; Department of Pathology and Cytology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.; Naidoo K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Gazinska P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Pancholi S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Martin LA; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Holgersen EM; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Cheang MCU; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, England, United Kingdom.; Noor F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Postel-Vinay S; Department of Drug Development (DITEP), Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; UMR981, ATIP-Avenir team, INSERM, Villejuif, France.; Quinn G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.; McDade S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.; Krasny L; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Huang P; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.; Daley F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Wallberg F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Choudhary JS; Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom.; Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Tutt AN; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom.; Natrajan R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom. rachael.natrajan@icr.ac.uk.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Koo CY; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom.; Giacomini C; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom.; Reyes-Corral M; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom.; Olmos Y; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom.; Tavares IA; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom.; Marson CM; Department of Chemistry, Christopher Ingold Laboratories, University College London, London, United Kingdom.; Linardopoulos S; Breast Cancer Now Toby Robins Research Centre, the Institute of Cancer Research, London, United Kingdom.; Tutt AN; Breast Cancer Now Toby Robins Research Centre, the Institute of Cancer Research, London, United Kingdom.; King's College London, School of Cancer Sciences, Breast Cancer Now Research Unit, Guy's Cancer Centre, Guy's Hospital, London, United Kingdom.; Morris JDH; King's College London, School of Cancer Sciences, New Hunt's House, Guy's Campus, Great Maze Pond, London, United Kingdom. jonathan.morris@kcl.ac.uk.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Cheung A; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Bax HJ; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Division of Cancer Studies, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Josephs DH; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Division of Cancer Studies, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Ilieva KM; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Pellizzari G; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Opzoomer J; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Bloomfield J; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Fittall M; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Grigoriadis A; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Figini M; Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Canevari S; Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Spicer JF; Division of Cancer Studies, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Tutt AN; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.; Karagiannis SN; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.; Breast Cancer Now Research Unit, Faculty of Life Sciences and Medicine, Guy's Hospital, King's College London, London, United Kingdom.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
McCabe N; Cancer Research UK Gene Function and Regulation Group and The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom.; Turner NCLord CJKluzek KBialkowska ASwift SGiavara SO'Connor MJTutt ANZdzienicka MZSmith GCAshworth A
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Tutt, Andrew N
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어